Establishment and Application of the Drug Use Evaluation Criteria on Recombinant Human Granulocyte-col-ony Stimulating Factor for Cancer Patients
10.6039/j.issn.1001-0408.2016.29.05
- VernacularTitle:肿瘤患者使用重组人粒细胞集落刺激因子DUE标准的建立与应用
- Author:
Ni YAN
;
Shenglin WU
;
Xia DU
;
Yirui WANG
;
Xia WANG
- Publication Type:Journal Article
- Keywords:
Drug use evaluation;
Cancer patrents;
Recombinant human granulocyte-colony stimulating factor;
Drug use evalu-ation criteria;
Rational drug use
- From:
China Pharmacy
2016;27(29):4050-4052,4053
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide reference for rational use of recombinant human granulocyte-colony stimulating factor (rhG-CSF) in cancer patients. METHODS:Referring to the expert advice and guideline of clinical application of rhG-CSF at home and abroad,DUE criteria on rhG-CSF for cancer patients was established;questionnaire was designed,and the medical re-cords of rhG-CSF in a third grade class A hospital was evaluated. RESULTS:The DUE criterion on rhG-CSF for cancer patients included 3 parts,such as drug indications,the course of medication and medication results,14 items in total. Through the imple-mentation of DUE,retrospective evaluation of 220 medical records showed that the application of rhG-CSF was up to the stan-dard in respects of drug indications,no contraindication,routine blood test and drug interaction monitoring at least twice every week,there still was irrational phenomenon. CONCLUSIONS:The established DUE criterion on rhG-CSF for cancer patients is with the characteristics of definite content,target and paracticabilitg,which can provide reference for the work development of clinical pharmacists.
